Navigation Links
Statement from the Consumer Healthcare Products Association on the Safety of Pediatric Over-the-Counter Medicines

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), in response to inaccurate and misleading media reports surrounding the U.S. Food and Drug Administration's upcoming joint meeting of the Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee scheduled for October 18 and 19:

"CHPA and the makers of pediatric, over-the-counter cough and cold medicines are committed to helping ensure the safe use of cough and cold medicines in children. Our highest priority is the safe use of our medicines.

"Recent media reports have misstated the FDA's position on the use of pediatric cough and cold medicines, and these inaccurate reports may unnecessarily alarm and confuse parents who have successfully relied on these medicines to relieve the cough and cold symptoms in their children for generations.

"FDA has not called for a ban on medicines for children under 6. Rather, the agency has presented a variety of internal and external recommendations for discussion at the upcoming advisory committee meeting.

"FDA's press office issued a note to correspondents yesterday further clarifying that 'the Agency has not reached any final decisions as to actions to be taken in response to a citizen petition ... Any review document included in this package that contains specific recommendations should not be considered final decisions by the Agency. After hearing the recommendations of the advisory committee, FDA will determine the course of action.'

"Parents can continue to trust over-the-counter cough and cold remedies for their children. The instructions on these medications have always clearly directed parents to 'Ask a Doctor' before administering to children under two. We strongly encourage parents to adhere to the recommended dosing instructions for all medicines, recognizing that the vast majority of adverse events associated with their use are due to inadvertent overdosing and misuse. When used as directed, these medicines are safe and effective.

"Based on our commitment to the health and wellbeing of our nation's families, and because children under age 2 are most vulnerable to misuse of over-the-counter cough and cold medicines, we are recommending that labeling for children under 2 be strengthened to read, 'Do Not Use' versus 'Ask a Doctor.' We also are recommending that language be added to the label of OTC antihistamines to read, 'Do not use to sedate children.'

"In the coming months, we'll be launching a major educational campaign alerting parents and caregivers to use great caution when administering medicines to children. Specifically, we will target parents and caregivers of children under two, as well as pediatricians, to further underscore that over- the-counter medicines should not be given to children under two.

"As the makers of over-the-counter cough and cold medicines for children, we remain committed to ensuring parents and caregivers have the information they need to use these medicines safely and effectively, and that they have access to the very best possible medicines for their children.

Editor's note: FDA has posted some recommendations for parents (link: 8#8 ) in addition to issuing a note to correspondents further clarifying that no final decision on recommendations has been made.

CHPA is the 126-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.

Contact: Elizabeth Funderburk

202.429.9260 (work)

202.256.5677 (cell)

SOURCE Consumer Healthcare Products Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. Consumer group seeks Sibutramine ban
4. Identifying What Consumers Look For On Food Stuff Labels
5. Consumers Becoming More Health Conscious Than Calorie Conscious
6. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
7. Consumers of soft drinks to be more alert
8. Consumers Worried About Trans-Fats The Most
9. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
10. Health care system “Consumer friendly” by 207
11. Chocolate makers to be health wise and urge consumers to be too!
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... ... 13, 2017 , ... Talented host, actor Rob Lowe, is ... a new episode of "Success Files," which is an award-winning educational program broadcasted ... each subject in-depth with passion and integrity. , Sciatica occurs when the sciatic ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
Breaking Medicine Technology: